Pharmacy
Lilly continues to offer 100% of 340B discounts to covered entities but will not provide discounts to contract pharmacies, it says.
Physicians say they hear: "You don't need a vaccine if you've had COVID-19," "The vaccine modifies your DNA," and "The vaccine contains a microchip."
This week's top stories include Scripps Health suspending access to its IT applications, the HRSA telling six drugmakers they're in violation of the 340B statute and Google previewing its AI-powered dermatology assistant.
The company is reportedly considering making an at-home COVID-19-testing kit available in June, then possibly kits for other respiratory infections.
The drug manufacturers have placed restrictions on the program that have resulted in overcharges, HRSA says.
Famed digital health pioneer Eric Topol called the term “breakthrough” COVID-19 infections “so off the mark.”
Four patients remained hospitalized as of Wednesday, with one in intensive care, and three patients have died.
This is the first vaccine to be approved in this age group.
The companies also intend to submit an application to expand use to individuals 12 to 15 years of age.
The policy would suspend the IP rights of manufacturers, enabling developing countries to manufacture their own vaccines.